Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

Lane HC, Davey V, Kovacs JA, Feinberg J, Metcalf JA, Herpin B, Walker R, Deyton L, Davey RT Jr, Falloon J, et al.

Ann Intern Med. 1990 Jun 1;112(11):805-11.

PMID:
1971503
3.

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD, et al.

Ann Intern Med. 1990 May 15;112(10):727-37.

PMID:
1970466
4.

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

Krown SE, Gold JW, Niedzwiecki D, Bundow D, Flomenberg N, Gansbacher B, Brew BJ.

Ann Intern Med. 1990 Jun 1;112(11):812-21. Erratum in: Ann Intern Med 1990 Aug 15;113(4):334.

PMID:
1971504
5.
6.

A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.

Davey RT Jr, Davey VJ, Metcalf JA, Zurlo JJ, Kovacs JA, Falloon J, Polis MA, Zunich KM, Masur H, Lane HC.

J Infect Dis. 1991 Jul;164(1):43-52.

PMID:
1676045
7.

Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)

Mulder JW, Cooper DA, Mathiesen L, Sandström E, Clumeck N, Gatell JM, French M, Donovan B, Gray F, Yeo JM, et al.

AIDS. 1994 Mar;8(3):313-21. Erratum in: AIDS 1994 Jun;8(6):following 859.

PMID:
7913326
8.

Low-dose oral natural human interferon-alpha in 29 patients with HIV-1 infection: a double-blind, randomized, placebo-controlled trial.

Kaiser G, Jaeger H, Birkmann J, Poppinger J, Cummins JM, Gallmeier WM.

AIDS. 1992 Jun;6(6):563-9. Erratum in: AIDS 1992 Sep;6(9):following 1051.

PMID:
1388878
9.
10.
11.

Lack of efficacy of low dose oral interferon alfa in symptomatic HIV-1 infection: a randomised, double blind, placebo controlled trial.

Katabira ET, Sewankambo NK, Mugerwa RD, Belsey EM, Mubiru FX, Othieno C, Kataaha P, Karam M, Youle M, Perriens JH, Lange JM.

Sex Transm Infect. 1998 Aug;74(4):265-70.

12.

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.

Meng TC, Fischl MA, Boota AM, Spector SA, Bennett D, Bassiakos Y, Lai SH, Wright B, Richman DD.

Ann Intern Med. 1992 Jan 1;116(1):13-20.

PMID:
1345755
13.

Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine.

Berglund O, Engman K, Ehrnst A, Andersson J, Lidman K, Akerlund B, Sönnerborg A, Strannegård O.

J Infect Dis. 1991 Apr;163(4):710-5.

PMID:
1672701
14.

Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1--infected patients (the EURIS study).

Gringeri A, Musicco M, Hermans P, Bentwich Z, Cusini M, Bergamasco A, Santagostino E, Burny A, Bizzini B, Zagury D.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 1;20(4):358-70.

PMID:
10096580
15.

An open study of interferon in HIV-antibody-positive men.

Ellis ME, Haeney MR, Craske J, Potter MR, Turner AJ, Shipman J, Blackburn N.

AIDS. 1989 Dec;3(12):851-3.

PMID:
2576630
17.

Use of recombinant interferon-alpha in human immunodeficiency virus (HIV)-infected individuals.

Rivero J, Limonta M, Aguilera A, Fraga M, López Saura P.

Biotherapy. 1994;8(1):23-31.

PMID:
7547078
19.

Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial.

Goldstein G, Conant MA, Beall G, Grossman HA, Galpin JE, Blick G, Calabrese LH, Hirsch RL, Fisher A, Stampone P, et al.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 1;8(3):279-88.

PMID:
7859140
20.

A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.

Fischl MA, Uttamchandani RB, Resnick L, Agarwal R, Fletcher MA, Patrone-Reese J, Dearmas L, Chidekel J, McCann M, Myers M.

J Acquir Immune Defic Syndr. 1991;4(1):1-10.

PMID:
1670585

Supplemental Content

Support Center